Evidence map›Paper›PMID 36361615›Full record

ArticleInternational journal of molecular sciences2022

Dual-Functionalized Nanoliposomes Achieve a Synergistic Chemo-Phototherapeutic Effect.

Ana Lazaro-Carrillo, Beatriz Rodríguez-Amigo, Margarita Mora, Maria Lluïsa Sagristá, Magdalena Cañete, Santi Nonell, Angeles Villanueva

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Special Issue "Application Progress of Liposomes in Drug Development".International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ana Lazaro-CarrilloDepartamento de Biología, Darwin 2, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Beatriz Rodríguez-AmigoDepartment of Biochemistry and Molecular Biomedicine, Facultat de Biologia, Universitat de Barcelona, 08028 Barcelona, Spain.
Margarita MoraDepartment of Biochemistry and Molecular Biomedicine, Facultat de Biologia, Universitat de Barcelona, 08028 Barcelona, Spain.
Maria Lluïsa SagristáDepartment of Biochemistry and Molecular Biomedicine, Facultat de Biologia, Universitat de Barcelona, 08028 Barcelona, Spain.
Magdalena CañeteDepartamento de Biología, Darwin 2, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Santi NonellInstitut Químic de Sarrià, Universitat Ramon Llull, Via Augusta 390, 08017 Barcelona, Spain.ORCID 0000-0002-8900-5291
Angeles VillanuevaDepartamento de Biología, Darwin 2, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Institut Químic de Sarrià · ESUniversidad Autónoma de Madrid · ESUniversitat de Barcelona · ESMadrid Institute for Advanced Studies · ES

Funding

Agencia Estatal de Investigación and FEDER PID2020-115801RB-C22/MICIN/AEI/10.13039/501100011033Ministry of Economy, Industry and Competitiveness CTQ2016-78454-C2-1-R and CTQ2016-78454-C2-2-R
6 · The paper itself

Abstract

The enhancement of photodynamic therapy (PDT) effectiveness by combining it with other treatment modalities and improved drug delivery has become an interesting field in cancer research. We have prepared and characterized nanoliposomes containing the chemotherapeutic drug irinotecan (CPT11

Indexed as

PhotochemotherapyCell Line, TumorHeLa CellsHumansIrinotecanPhotosensitizing AgentsIrinotecanPhotosensitizing Agentsbimodal-functionalized nanoliposomeschemo-phototherapydouble-strand DNA breakirinotecanphotodynamic therapyprotoporphyrin IXreactive oxygen speciessubcellular locationsynergistic effecttime-lapse microscopy

Identifiers

PMID36361615
PMCPMC9653560
OpenAlexW4307262283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.